stockrowZimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
Follow ZBH
Alert me
Zimmer Biomet Holdings, Inc. (ZBH) Net income
Zimmer Biomet Holdings, Inc.'s net income for fiscal 2025 was $705.1M, down 22.1% from $905.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $768.8M. Over the past ten years it has ranged from −$379.3M (fiscal 2018) to $1.8B (fiscal 2017); the current reading is higher than 64% of that period. Zimmer Biomet Holdings, Inc. ranks 11th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $705.1M | (22.11%) |
| FY2024 | $905.2M | (11.70%) |
| FY2023 | $1.0B | 252.03% |
| FY2022 | $291.2M | (34.64%) |
| FY2021 | $445.5M | — |
| FY2020 | −$9.2M | — |
| FY2019 | $1.1B | — |
| FY2018 | −$379.3M | — |
| FY2017 | $1.8B | 495.34% |
| FY2016 | $304.6M | 108.34% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $193.0M | (3.31%) |
| Jun 2026 | $199.6M | (16.24%) |
| Mar 2026 | $238.3M | 72.81% |
| Dec 2025 | $137.9M | (40.35%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| PHG Koninklijke Philips N.V. compare | $1.1B |
| DXCM DexCom, Inc. compare | $991.0M |
| STE STERIS plc compare | $829.8M |
| ZBH Zimmer Biomet Holdings, Inc. | $768.8M |
| GMED Globus Medical, Inc. compare | $557.6M |
| PODD Insulet Corporation compare | $428.8M |
| PEN Penumbra, Inc. compare | $157.0M |
| GKOS Glaukos Corporation compare | −$169.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on ZBH
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement